Clearstead Advisors’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.92K Buy
+1,280
New +$6.34K ﹤0.01% 2144
2026
Q1
– Sell
-747
Closed -$3.74K – 2629
2025
Q4
$3.74K Sell
747
-6,511
-90% -$33.9K ﹤0.01% 2074
2025
Q3
$36.8K Buy
+7,258
New +$32K ﹤0.01% 1389
2025
Q2
– Sell
-383
Closed -$2.31K – 2825
2025
Q1
$2.31K Buy
+383
New +$1.94K ﹤0.01% 1879
2024
Q2
– Sell
-362
Closed -$2.02K – 2053
2024
Q1
$2.02K Buy
+362
New +$1.39K ﹤0.01% 1307
2022
Q1
– Sell
-891
Closed -$21K – 1431
2021
Q4
$21K Hold
891
– – ﹤0.01% 818
2021
Q3
$18K Buy
+891
New +$18.3K ﹤0.01% 846

Other funds holding MPT

Clearstead Advisors's MPT Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Medical Properties Trust (MPT) in Q2 2026: 1,280 shares worth $5.92K. The stake represents ﹤0.01% of the portfolio and ranks #2144 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in MPT as recently as Q4 2025.

Clearstead Advisors first reported a position in MPT in Q3 2021 and has held it in 7 quarters since. The position peaked at $36.8K in Q3 2025. 490 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

  • Clearstead Advisors held 1,280 shares of Medical Properties Trust worth $5.92K as of Q2 2026.
  • Medical Properties Trust was a new Clearstead Advisors position in Q2 2026.
  • Medical Properties Trust made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2144 holding.
  • Clearstead Advisors first reported a position in Medical Properties Trust in Q3 2021 and has held it in 7 quarters since.
  • Clearstead Advisors's Medical Properties Trust position peaked at $36.8K in Q3 2025.
  • 490 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.